Abstract
Although cell membranes have potent inhibitors which protect the activation of complement on the self cell membranes, some viruses have been shown to activate complement via the alternative pathway on the virus-infected cells. Tumour cells have been made reactive to homologous complement following treatment with such viruses and became highly immunogenic to syngeneic host guinea pigs and mice. Vaccinia virus (VV) made murine tumour cells highly immunogenic thus generating complement activating capacity on the infected cells. Since it has been suggested that VV can make some human tumour cells immunogenic to the cancer patients, we examined VV to see if the virus also has the capacity to make human tumour cells reactive with homologous human complement. Our present results indicate that not only is this the case but ultraviolet-treated VV also has the same effect.
Key words: Complement, Immunogenicity
References
- 1.Hersey P, Edwars A, D'Alessandro G, MacDonald M. Phase II study of vaccinia melanoma cell lysates (VMCL) as adjuvant to surgical treatment of stage II melanoma. Cancer Immunol Immunother. 1986;22:221. doi: 10.1007/BF00200037. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Hugli TE, Muller-Eberhard HJ. Anaphylatoxins: C3a and C5a. Adv Immunol. 1978;26:1. doi: 10.1016/s0065-2776(08)60228-x. [DOI] [PubMed] [Google Scholar]
- 3.Joklik WK. The purification of four strains of poxvirus. Virology. 1962;18:9. doi: 10.1016/0042-6822(62)90172-1. [DOI] [PubMed] [Google Scholar]
- 4.McConnell I, Klein G, Lint TF, Lachmann PJ. Activation of the alternative complement pathway by human B cell lymphoma lines is associated with Epstein-Barr virus transformation of the cells. Eur J Immunol. 1978;8:453. doi: 10.1002/eji.1830080702. [DOI] [PubMed] [Google Scholar]
- 5.Muller-Eberhard HJ, Schreiber RD. Molecular biology and chemistry of the alternative pathway of complement. Adv Immunol. 1980;29:1. doi: 10.1016/s0065-2776(08)60042-5. [DOI] [PubMed] [Google Scholar]
- 6.Nakamura S, Goto F, Goto K, Yoshinaga M. Physioco-chemical characterization of a PMN-derived soluble factor that enhances lymphocyte DNA synthesis. J Immunol. 1982;128:2614. [PubMed] [Google Scholar]
- 7.Ohta H, Yoshikawa Y, Kai C, Yamanouchi K. Activation of chicken alternative complement pathway by fowlpox virus-infected cells. Infect Immun. 1983;42:29. doi: 10.1128/iai.42.2.721-727.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Okada H, Baba T. Rosette-formation of human erythrocytes on cultured cells of tumor origin and activation of complement by cell membrane. Nature. 1974;248:521. doi: 10.1038/248521a0. [DOI] [PubMed] [Google Scholar]
- 9.Okada H, Tanaka H. Species-specific inhibition by glycophorin of complement activation via the alternative pathway. Mol Immunol. 1983;20:1233. doi: 10.1016/0161-5890(83)90148-7. [DOI] [PubMed] [Google Scholar]
- 10.Okada N, Shibuta H, Okada H. Activation of the alternative pathway of guinea pig complement by Sendai virus treated cells. Microbiol Immunol. 1979;23:689. doi: 10.1111/j.1348-0421.1979.tb00511.x. [DOI] [PubMed] [Google Scholar]
- 11.Okada H, Tanaka H, Okada N. Prevention of complement activation on the homologous cell membrane of nucleated cells as well as erythrocytes. Eur J Immunol. 1983;13:340. doi: 10.1002/eji.1830130413. [DOI] [PubMed] [Google Scholar]
- 12.Okada H, Tanaka H, Okada N. Cytolysis of Sendai virus-infected guinea-pig cells by homologous complement. Immunology. 1983;49:29. [PMC free article] [PubMed] [Google Scholar]
- 13.Okada H, Tanaka H, Okada N. Basic mechanisms and clinical treatment of tumor metastasis. New York: Academic Press; 1985. Increased immunogenicity of tumor cells by induction of complement activating capacity of cell membrane; p. 255. [Google Scholar]
- 14.Rocklin RE, Bendtzen K, Greineder RD. Mediators of immunity: lymphokines and monokines. Adv Immunol. 1980;29:55. doi: 10.1016/s0065-2776(08)60043-7. [DOI] [PubMed] [Google Scholar]
- 15.Shimizu Y, Fujiwara H, Ueda S, Wakamiya N, Kato S, Hamaoka T. The augmentation of tumor-specific immunity by virus help. II. Enhanced induction of cytotoxic T lymphocytes and antibody response to tumor antigens by vaccinia virus-reactive T cells. Eur J Immunol. 1984;14:839. doi: 10.1002/eji.1830140913. [DOI] [PubMed] [Google Scholar]
- 16.Sissons JGP, Oldstone NBA, Schreiber RD. Antibody-independent activation of the alternative complement pathway by measles virus-infected cells. Proc Natl Acad Sci USA. 1980;77:559. doi: 10.1073/pnas.77.1.559. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Wakamiya N, Okada N, Wang Y, Ito T, Ueda S, Kato S, Okada H (1987) Activation of murine alternative complement pathway by vaccinia virustreated cells (in press)